lc51-0255
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 31, 2017 (NCT03174613)
Timeline
Indications
Mechanism of action
S1PR1 modulator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- lc51-0255
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04096573 | Phase 2 | Apr 30, 2020 | LG |
| NCT03174613 | Phase 1 | May 31, 2017 | LG, Seoul National University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| LG | For profit | 2 | 2 | 2 | 2017 |
| Seoul National University | Academic/Hospital | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1